HR 1672 · 119th Congress 2025โ€“2027

Maintaining Investments in New Innovation Act

Latest action · Feb 27, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedFeb 27, 2025
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Maintaining Investments in New Innovation Act

This bill requires drug products with genetically targeted technology to have had market approval for at least 11 years in order to qualify for the Medicare Drug Price Negotiation Program. (The program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.)

Cosponsors 51

Members who signed on, in the order they did. Signatures ran from Feb 27, 2025 to Sep 24, 2026; 13 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-FLAaron BeanOriginalFeb 27, 2025
R-TXBeth Van DuyneOriginalFeb 27, 2025
R-UTBlake D. MooreOriginalFeb 27, 2025
R-NYClaudia TenneyOriginalFeb 27, 2025
R-TXDan CrenshawOriginalFeb 27, 2025
R-PAJohn JoyceOriginalFeb 27, 2025
D-NYJoseph D. MorelleOriginalFeb 27, 2025
D-NJJosh GottheimerOriginalFeb 27, 2025
R-IAMariannette Miller-MeeksOriginalFeb 27, 2025
R-NCRichard HudsonOriginalFeb 27, 2025
R-GARick W. AllenOriginalFeb 27, 2025
R-INRudy Yakym IIIOriginalFeb 27, 2025
D-CAScott H. PetersOriginalFeb 27, 2025
R-FLNeal P. DunnMar 27, 2025
R-OKKevin HernApr 9, 2025

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Feb 27, 2025
HouseWays and Means Committee
Referred Feb 27, 2025

Actions 2

Everything that happened, newest first.

  1. Feb 27, 2025Introduced in House
  2. Feb 27, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8, Clause 18.

The sponsor’s statement, as printed in the Congressional Record, vol. 171, no. 39, February 27, 2025, page H919.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
Serial No. 119-46MEMBER DAY248 pagesEnergy and Commerce CommitteeDec 12, 2025

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend title XI of the Social Security Act to protect access to genetically targeted technologies.
Short Title(s) as Introduced
Maintaining Investments in New Innovation Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Feb 27, 2025Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.